Column 1 0 Purpose of capital - see 3B announcement. No mention of last point below in original announcement.....
• To continue of our ongoing clinical development of IMP321;
- • To continue our preclinical development of IMP761;
- • For general corporate purposes;
- • We may also use a portion of the net proceeds to acquire or invest in businesses, products and technologies that we view as complementary to our own.
Purpose of capital - see 3B announcement. No mention of last...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.005(1.64%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.5¢ | 30.5¢ | $491.3K | 1.584M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 95404 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 423452 | 38 |
View Market Depth
| Last trade - 13.59pm 25/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
